| Title |
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
|
|---|---|
| Published in |
Journal of Molecular Medicine, October 2009
|
| DOI | 10.1007/s00109-009-0547-z |
| Pubmed ID | |
| Authors |
Giovanni Mantovani, Antonio Macciò, Clelia Madeddu, Roberto Serpe, Giorgia Antoni, Elena Massa, Mariele Dessì, Filomena Panzone |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Portugal | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 97 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 18 | 18% |
| Researcher | 15 | 15% |
| Student > Master | 9 | 9% |
| Student > Bachelor | 9 | 9% |
| Student > Postgraduate | 8 | 8% |
| Other | 18 | 18% |
| Unknown | 24 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 30% |
| Agricultural and Biological Sciences | 10 | 10% |
| Biochemistry, Genetics and Molecular Biology | 8 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
| Nursing and Health Professions | 5 | 5% |
| Other | 14 | 14% |
| Unknown | 28 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2017.
All research outputs
#18,518,987
of 22,940,083 outputs
Outputs from Journal of Molecular Medicine
#1,251
of 1,551 outputs
Outputs of similar age
#85,880
of 94,039 outputs
Outputs of similar age from Journal of Molecular Medicine
#18
of 19 outputs
Altmetric has tracked 22,940,083 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,551 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,039 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.